Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy.
This study evaluated the prognostic roles of murine double minute 2 (MDM2) and p53 in pancreatic cancer patients treated with gemcitabine-based chemotherapy. A total of 137 advanced or recurrent adenocarcinoma patients who were treated with gemcitabine-based palliative chemotherapy were reviewed, se...
Main Authors: | Shih-Hung Yang, Jen-Chieh Lee, Jhe-Cyuan Guo, Sung-Hsin Kuo, Yu-Wen Tien, Ting-Chun Kuo, Ann-Lii Cheng, Kun-Huei Yeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5498069?pdf=render |
Similar Items
-
Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients
by: Shih-Hung Yang, et al.
Published: (2020-01-01) -
GDF11 upregulation independently predicts shorter overall-survival of uveal melanoma.
by: Xun Liu, et al.
Published: (2019-01-01) -
KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma.
by: Ozlen Saglam, et al.
Published: (2020-01-01) -
LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype.
by: Sumadi Lukman Anwar, et al.
Published: (2019-01-01) -
Ectopic fat in liver and skeletal muscle is associated with shorter overall survival in patients with colorectal liver metastases
by: David P.J. vanDijk, et al.
Published: (2021-08-01)